This study is looking at an experimental treatment for liver cancer that can’t be treated with surgery.
The purpose of this study is to compare the effects of an investigational drug to a medication that has been approved for treating liver cancer (hepatocellular carcinoma). Patients will be randomly assigned to receive the study drug or the standard approved medication.
What we're hoping for
We hope to learn if the experimental drug is safe and effective in treating this type of cancer.
ClinicalTrials.gov Identifier: NCT03412773